Affinity Asset Advisors »

Amanat Acquisition Corp shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Amanat Acquisition Corp shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Amanat Acquisition Corp

Tip: Access up to 7 years of quarterly data

All positions including Amanat Acquisition Corp held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amanat Acquisition Corp by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.8M 375k 10.16

More positions owned by Affinity Asset Advisors

Roivant Sciences SHS (ROIV)
Apogee Therapeutics (APGE)
Spyre Therapeutics Com New (SYRE)
Xenon Pharmaceuticals (XENE)
Erasca (ERAS)
Alkermes SHS (ALKS)
Insmed Com Par $.01 (INSM)
Moderna Put Option (MRNA)
Praxis Precision Medicines I Com New (PRAX)
Oruka Therapeutics (ORKA)
Anaptysbio Inc Common (ANAB)
Avalo Therapeutics Com New (AVTX)
Cytokinetics Com New (CYTK)
Revolution Medicines (RVMD)
Abivax Sa Sponsored Ads (ABVX)

View all positions for Affinity Asset Advisors

Top funds holding Amanat Acquisition Corp

Nantahala Capital Management
ADAR1 Capital Management
OZ Management
Braidwell
Dr. Jeffrey R. Jay, M.D.
RA Capital Management
Affinity Asset Advisors
Toronto-Dominion Bank
Citadel Advisors
Millennium Management
Aristeia Capital
Ikarian Capital
Mizuho Securities Usa
Two Sigma Investments
Lineage Point Capital

View all funds holding Amanat Acquisition Corp